Mylan's CEO Showed 'Very Little Empathy,' Bill George Says

Bill George, a Harvard Business School senior fellow and ex-chairman of Medtronic PLC MDT has some harsh words for Mylan NV MYL's CEO Heather Bresch.

Speaking as a guest on CNBC's "Squawk On The Street" on Wednesday, George said that Bresch could be in for a "rough time" as she is set to defend the company's policy of boosting the price of its life saving EpiPen in front of the U.S. Congress.

George even went on to say that Bresch "deserves it," especially after saying outrageous comments that "no one believes," including a claim Mylan doesn't make much money from the sale of its EpiPen.

Related Link: Mylan Investors Should Be Asking Where (And Who) Robert Coury Is

George continued that Bresch has tried to "obfuscate the issue by blaming the insurance companies and blaming everyone else."

"You don't take advantage of the consumer with rapid price increases like they have because you are going to get pushed back," he argued.

At the very least, George suggested Mylan roll back the price of its EpiPen to last year's level. He added that Bresch is even "harming people" and an apology is needed.

He also pointed out that executives at Mylan as a whole enjoy the second highest level of pay within the entire industry, which should be concerning since the company has "never invented a drug."

"I don't see how you can justify this," he added. "I think she has to apologize and get out front of the issue instead of being on the defensive and try to blame everyone else."

Bottom line, Bresch needs to change her tone as she has shown "very little empathy for the consumer."

Full ratings data available on Benzinga Pro.